Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 12/20 | 0.49 |
| ▸ | PDGFRB | P09619 | 10/20 | 0.49 |
| ▸ | FGFR1 | P11362 | 7/20 | 0.49 |
| ▸ | KIT | P10721 | 5/20 | 0.48 |
| ▸ | FLT1 | P17948 | 4/20 | 0.47 |
| ▸ | FLT3 | P36888 | 6/20 | 0.46 |
| ▸ | RET | P07949 | 4/20 | 0.46 |
| ▸ | TLK2 | Q86UE8 | 3/20 | 0.46 |
| ▸ | MET | P08581 | 3/20 | 0.46 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.46 |
| ▸ | MAP4K2 | Q12851 | 3/20 | 0.46 |
| ▸ | STK3 | Q13188 | 3/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.46 |
| ▸ | LCK | P06239 | 3/20 | 0.46 |
| ▸ | RIOK2 | Q9BVS4 | 2/20 | 0.46 |
| ▸ | TLK1 | Q9UKI8 | 2/20 | 0.46 |
| ▸ | PLK4 | O00444 | 2/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.46 |
| ▸ | GAK | O14976 | 2/20 | 0.46 |
| ▸ | CHUK | O15111 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6329050 | 0.89 | KDR (0.46) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6319633 | 0.87 | KDR (0.52) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6321484 | 0.86 | KDR (0.44) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6327103 | 0.86 | KDR (0.58) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6319478 | 0.79 | KDR (0.43) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6323841 | 0.79 | PDGFRB (0.57) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6324754 | 0.78 | KDR (0.42) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6323389 | 0.78 | KDR (0.42) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6322625 | 0.78 | KDR (0.60) | KDRPDGFRBFGFR1KITFLT1 | |
| SCHEMBL6322958 | 0.77 | KDR (0.46) | KDRPDGFRBFGFR1KITFLT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861418-B2 | 4-aryl substituted indolinones | SUGEN, INC. (US) | 2005-03-01 | — | — | US | disclosed |
| US-20040157909-A1 | 4-Aryl substituted indolinones | SUGEN, INC. | 2004-08-12 | — | — | US | disclosed |
| US-6677368-B2 | 4-aryl substituted indolinones | SUGEN, INC. | 2004-01-13 | — | — | US | disclosed |
| US-20030069297-A1 | 4-aryl substituted indolinones | SUGEN, INC. | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069297-A1 | 4-aryl substituted indolinones | CDK5, CAMK4, TNK2 | KDR 819/4885PDGFRB 575/4885FGFR1 525/4885 |
| US-20040157909-A1 | 4-Aryl substituted indolinones | CDK5, CAMK4, TNK2 | KDR 819/4885PDGFRB 575/4885FGFR1 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.